1. Benefits of resection for metachronous lung cancer
Richard J Battafarano, MD, PhD, Seth D Force, MD, Bryan F Meyers, MD, Jennifer Bell, BSN, Tracey J Guthrie, BSN, Joel D Cooper, MD, G.Alexander Patterson, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 127, Issue 3, Pages (March 2004)
DOI: /j.jtcvs

2. Figure 1
Five-year actuarial survival from the time of the first resection of the entire group stratified by the stage of the primary NSCLC.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )

3. Figure 2
Five-year actuarial survival from the time of the second resection of the entire group stratified by the stage of the metachronous NSCLC.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )

4. Figure 3
Five-year actuarial survival from the time of the second resection of the entire group stratified by tumor histology.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )

5. Figure 4
Five-year actuarial survival from the time of the second resection of the entire group stratified by the interval between resections.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )